Resultados de Búsqueda por Autor

1

artículo

Human space medicine: Physiological performance and countermeasures to improve the astronaut's health: Medicina humana espacial: Performance fisiológico y contramedidas para mejora...

Publicado por
V. Rivera, Milton, Cornejo, José, Huallpayunca, Karen, Diaz, Aurora B., Ortiz-Benique, Zhamanda N., Reina, Andrés D., Jamanca Lino, Gustavo, Ticllacuri, Victor

Publicado 2020

Enlace

This Review Article is presented based on current scientific evidence on space medicine focused on human physiology and its countermeasures. Therefore, a non-systematic bibliographic search of scientific articles and research books in English-Spanish of the last 7 years was carried out, detailing their application in humans, murine models and in vitro experiments. The conditions of the space environment such as microgravity and radiation that produce considerable physiological changes in the cardiovascular system (redistribution of fluids, cardiovascular remodeling, arrhythmias) were taken into account; nervous (sensorimotor, neurosensory, neurovestibular); respiratory (volume and capacity changes); renal (lithiasis); musculoskeletal (muscular atrophy, osteoporosis); hematological (anemia); immunological (immune dysregulation) and digestive (intestinal microbiota disorder). In addition, ...

2

artículo

Human space medicine: Physiological performance and countermeasures to improve the astronaut's health

Publicado por
V. Rivera, Milton, Cornejo, José, Huallpayunca, Karen, Diaz, Aurora B., Ortiz-Benique, Zhamanda N., Reina, Andrés D., Jamanca Lino, Gustavo, Ticllacuri, Victor

Publicado 2020

Enlace

This Review Article is presented based on current scientific evidence on space medicine focused on human physiology and its countermeasures. Therefore, a non-systematic bibliographic search of scientific articles and research books in English-Spanish of the last 7 years was carried out, detailing their application in humans, murine models and in vitro experiments. The conditions of the space environment such as microgravity and radiation that produce considerable physiological changes in the cardiovascular system (redistribution of fluids, cardiovascular remodeling, arrhythmias) were taken into account; nervous (sensorimotor, neurosensory, neurovestibular); respiratory (volume and capacity changes); renal (lithiasis); musculoskeletal (muscular atrophy, osteoporosis); hematological (anemia); immunological (immune dysregulation) and digestive (intestinal microbiota disorder). In addition, ...

3

artículo

Guía de práctica clínica para el tratamiento farmacológico inicial de nefritis lúpica en el Seguro Social del Perú (EsSalud)

Publicado por
Ugarte Gil, Manuel Francisco, Goicochea Lugo, Sergio, Romero Robles, Milton A., Ortiz Benique, Zhamanda N., Ugaz Zegarra, Milko, Rodríguez Mori, Juan E., Gomez Lujan, Martin, Gutierrez Vargas, Mirella, Lumbe Vidia Diaz, Guevara Rodríguez, Luis, De la Jara, Jesús, Perez Medina, Wilkerson, Huamanyari Saavedra, Paolo, Hostia Cardeña, Alvaro, Sottec Roque, Valentin, Vilca Flores, Miguel, Vargas Marquez, Sandra, Delgado Flores, Carolina J., García Gomero, David, Dolores Maldonado, Gandy, Taype Rondan, Alvaro, Salvador Salvador, Stefany, Carrera Acosta, Lourdes

Publicado 2021

Enlace

Introducción: El presente artículo resume la guía de práctica clínica (GPC) para el tratamiento farmacológico inicial nefritis lúpica en el Seguro Social del Perú (EsSalud). Objetivo: Proveer recomendaciones clínicas basadas en evidencia para tratamiento farmacológico inicial de adultos con nefritis lúpica clase I a V no refractarios en EsSalud. Material y Métodos: Se conformó un grupo elaborador de la guía (GEG) que incluyó médicos especialistas y metodólogos, el cual formuló preguntas clínicas. Se realizaron búsquedas sistemáticas de revisiones sistemáticas y –cuando fue considerado pertinente– estudios primarios en PubMed durante el 2021. Se seleccionó la evidencia para responder cada una de las preguntas clínicas planteadas. Se evaluó la certeza de evidencia usando la metodología Grading of Recommendations Assessment, Development, and Evaluation (GRADE)....

4

artículo

Clinical practice guideline for the initial pharmacological treatment of lupus nephritis in the Peruvian Social Security (EsSalud)

Publicado por
Ugarte-Gil, Manuel Francisco, Goicochea-Lugo, Sergio, Romero-Robles, Milton A., Ortiz-Benique, Zhamanda N., Ugaz-Zegarra, Milko, Rodríguez-Mori, Juan E., Gomez-Lujan, Martin, Gutierrez-Vargas, Mirella, Lumbe-Diaz, Vidia, Guevara-Rodríguez, Luis, De la Jara, Jesús, Perez-Medina, Wilkerson, Huamanyauri-Saavedra, Paolo, Hostia-Cardeña, Alvaro, Sottec-Roque, Valentin, Vilca-Flores, Miguel, Vargas-Marquez, Sandra, Delgado-Flores, Carolina J., García-Gomero, David, Dolores-Maldonado, Gandy, Taype-Rondan, Alvaro, Salvador-Salvador, Stefany, Carrera-Acosta, Lourdes

Publicado 2021

Enlace

Background: This article summarizes the clinical practice guideline (CPG) for the initial pharmacological treatment of lupus nephritis in the Social Security of Peru (EsSalud). Objective: To provide evidence-based clinical recommendations for initial pharmacological treatment of non-refractory adults with class I to V lupus nephritis in EsSalud. Material and Methods: A guideline development group (GDG) was formed, which included specialist physicians and methodologists, who formulated clinical questions. Systematic searches were conducted for systematic reviews and - when deemed relevant - primary studies in PubMed during 2021. Evidence was selected to answer each of the clinical questions posed. The certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In periodic working meetings, the GEG used the GRADE meth...